Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin added to fluoxetine for anxiety disorders in children
IRCT20170108031818N5Phase 3Completed
- Sponsor
- Golestan University of Medical Sciences
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of pregabalin and fluoxetine in anxiety disorder, sponsored by Golestan University of Medical Sciences. Started Sep 2023; status: completed.
02
Drugs
pregabalinfluoxetine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on IRCT20170108031818N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170108031818N5.